Project Grant R56AR082484
Award Date
9/20/24
Completion Date
8/31/25
Dollars Obligated
$344K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94158, USA
Similar Awards
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) provides $176,148 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the role of PI16-expressing fibroblasts in mouse and human fibrosing skin disease. The 5-year research project aims to elucidate how this specific fibroblast subset responds to and...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) provides $144,362 to Rockefeller University to investigate the long-term effects of type 2 skin inflammation on epithelial stem cells. The project aims to uncover how allergic inflammatory exposures, driven by the epithelial alarmin thymic stromal lymphopoietin (TSLP), impact the functional responsiveness and epigenetic...
This $706,710 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will fund research at Virginia Commonwealth University (VCU) to investigate the role of sphingolipid biosynthesis in the epidermal barrier for healthy and diseased skin. The research aims to understand how unique sphingoid backbones generated by the serine palmitoyltransferase (SPT) enzyme...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $550,909 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to the University of Pittsburgh. This 5-year award, effective July 20, 2024 through June 30, 2029, supports research to understand the intrinsic and extrinsic factors regulating the development and persistence of skin-resident memory CD8 T cells. The research aims to elucidate how T cell...
This $170,490 project grant awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will support research aimed at developing tools and methods to enable comparative effectiveness research (CER) on systemic treatments for pediatric atopic dermatitis. The key products and services to be delivered include:
Development and validation of computable phenotypes to accurately...
This $126,174 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports a research project conducted by the University of California, Davis to investigate local immune responses and granulopoiesis (production of neutrophils) in the skin using a novel skin-on-a-chip model.
The key objectives of the project are to: 1) Demonstrate that the SDF-1/CXCR4 signaling axis, which regulates hematopoietic stem and...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $100,138 project grant (CFDA# 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to Harvard Medical School to investigate the role of Staphylococcus aureus-induced itch and neuro-immune signaling in driving skin barrier damage and immune responses in atopic dermatitis. The research project, running from August 2024 to July 2026, aims to define how S. aureus and its V8 protease impact skin...
This $230,212 project grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will support research to investigate how immune cells in the skin can drive functional heterogeneity in skin epithelial stem cells. The project aims to 1) examine how direct contact with dendritic epidermal T cells (DETC) mediates functional specification of stem cells within the hair...
This Project Grant award in the amount of $147,400 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The funding will support research by Yale University to investigate how antigen-independent activation of CD4+ T cells regulates skin fibrosis in scleroderma and sclerodermatous graft-versus-host disease. The research aims to characterize the role of...
This $1,672,816 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will support research at the University of Michigan to investigate how keratinocyte-derived signals regulate inflammation and innate immune responses in skin. The 5-year project aims to: 1) compare the spatiotemporal patterns of immune cell infiltration and protein kinase C activity in...